Isolation of a menadione-resistant subclone from Chinese hamster lung (CHL) cells in culture.
Menadione-resistant subclones were selected from cultured Chinese hamster lung (CHL) cells which had been mutagenized with MNNG or ENU. The frequency of surviving colonies and the level of resistance were higher in mutagenized cells than in non-mutagenized cells. A subclone (designated MM1) was isolated from MNNG-treated cells and showed the highest level of resistance, 3 times higher than the parental CHL cells. The level of resistance was stable in non-selective medium over 3 months. The MM1 cells were also 2-3 times more resistant to other naphthoquinones. The activity of NADPH-cytochrome P-450 reductase, which is thought to play an important role in activation of menadione, was reduced in the MM1 cells to half that in the parental CHL cells. On the other hand, no differences between MM1 and CHL cells were found in the activity of superoxide dismutase and catalase which are assumed to defend against the cytotoxicity of menadione. Karyotype analyses indicated that one small chromosome was lost in the MM1 cells. The MM1 cells showed a 3-fold resistance to menadione in the chromosomal aberration test. The frequencies of chromosomal aberrations induced by adriamycin and mitomycin C which could be activated by NADPH-cytochrome P-450 reductase were almost the same in the MM1 and CHL cells, suggesting that the reductive activation of these compounds by this enzyme in microsomes may not be involved in the induction of chromosomal aberrations.
Sawada
M
M
Division of Genetics and Mutagenesis, National Institute of Hygienic Sciences, Tokyo, Japan.
Sofuni
T
T
Ishidate
M
M
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D002871:Chromosome Banding; D006224:Cricetinae; D003412:Cricetulus; D004317:Doxorubicin / Q000633:toxicity; D005038:Ethylnitrosourea / Q000633:toxicity; D007621:Karyotyping; D008168:Lung / Q000166:cytology / Q000187:drug effects*; D008769:Methylnitronitrosoguanidine / Q000633:toxicity; D016685:Mitomycin; D008937:Mitomycins / Q000633:toxicity; D016296:Mutagenesis; D009251:NADPH-Ferrihemoprotein Reductase / Q000378:metabolism; D009285:Naphthoquinones / Q000633:toxicity; D013481:Superoxides; D014812:Vitamin K / Q000235:genetics / Q000633:toxicity*
D008937:Mitomycins; D009285:Naphthoquinones; D013481:Superoxides; D014812:Vitamin K; D008769:Methylnitronitrosoguanidine; D016685:Mitomycin; D004317:Doxorubicin; D009251:NADPH-Ferrihemoprotein Reductase; D005038:Ethylnitrosourea